These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6399038)

  • 21. [The antimycotic activity of pentamycin].
    Cusumano V; Zamboni C; Leonardi MS
    G Ital Chemioter; 1977; 24(1-2):109-11. PubMed ID: 355034
    [No Abstract]   [Full Text] [Related]  

  • 22. [Antimycotic sensitivity of yeasts from the intestinal tract. Comparative studies with the serial dilution test and disk diffusion test].
    Gehse M; Blesch A; Braun KJ; Gloor M
    Fortschr Med; 1988 Jan; 106(3):47-9. PubMed ID: 3280450
    [No Abstract]   [Full Text] [Related]  

  • 23. [In vitro nystatin sensitivity of vaginal isolates of Candida spp].
    Andreu CM; Medina YE; Gonzáles TC; Llanes DM
    Rev Cubana Med Trop; 2001; 53(3):194-8. PubMed ID: 15846923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of clotrimazole for Candida strains isolated from recent patient samples.
    Schmidt A
    Arzneimittelforschung; 1995 Dec; 45(12):1338-40. PubMed ID: 8595097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antimycotic sensitivities of the clinically isolated candidas].
    Akgün Y; Akşit F
    Mikrobiyol Bul; 1981 Jul; 15(2):112-20. PubMed ID: 7052253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antifungal agents. 7. Dichlorophenylpyrrylimidazolylmethane derivatives: synthesis and antifungal activities.
    Massa S; Mai A; Ragno R; Porretta GC; Retico A; Simonetti G; Artico M
    Farmaco; 1994 Jan; 49(1):51-5. PubMed ID: 8185750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Investigation of quantitative and species composition and antifungal drug susceptibility of yeasts isolated from patients with generalized periodontitis complicated by candidosis].
    Kutsyk RV; Pavliuk TD
    Mikrobiol Z; 2003; 65(5):26-9. PubMed ID: 14723159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Activity of the azole drugs in vitro against strains of Candida albicans with different codes isolated from the digestive tract in children].
    Kurnatowski M; Kurnatowska A; Wasowska-Królikowska K
    Wiad Parazytol; 2004; 50(3):387-92. PubMed ID: 16865942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.
    Paniagua GL; Monroy E; Negrete E; Vaca S
    Rev Latinoam Microbiol; 2002; 44(2):65-8. PubMed ID: 17063773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Screening of Candida albicans fluconazole--resistant mutation strains].
    Wang W; Zhang B; Wang X; Liu Y; Wang D
    Wei Sheng Wu Xue Bao; 1997 Jun; 37(3):212-6. PubMed ID: 9863212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro synergistic activity of ketoconazole with valproic acid against Candida species.
    Krajewska-Kułak E; Niczyporuk W
    Arzneimittelforschung; 1996 Sep; 46(9):934-6. PubMed ID: 8876946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fungicidal effect of three new synthetic cationic peptides against Candida albicans.
    Nikawa H; Fukushima H; Makihira S; Hamada T; Samaranayake LP
    Oral Dis; 2004 Jul; 10(4):221-8. PubMed ID: 15196144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biofilms of Candida albicans and their associated resistance to antifungal agents.
    Ramage G; Wickes BL; Lopez-Ribot JL
    Am Clin Lab; 2001 Aug; 20(7):42-4. PubMed ID: 11570274
    [No Abstract]   [Full Text] [Related]  

  • 34. [In vitro activity of fluconazole against Candida albicans isolated from blood culture].
    Pemán J; Cantón E; Orero A; Ubeda P; Viudes A; Pastor A; Gobernado M
    Rev Esp Quimioter; 1998 Dec; 11(4):339-43. PubMed ID: 10336314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antifungal susceptibility and genotypes of Candida albicans strains from patients with vulvovaginal candidiasis.
    Liu XP; Fan SR; Bai FY; Li J; Liao QP
    Mycoses; 2009 Jan; 52(1):24-8. PubMed ID: 18498300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antimycotic behavior of monodesmosidic astrantia saponins].
    Hiller K; Matejik E; Woitke HD; Friedrich E
    Pharmazie; 1975 Feb; 30(2):114. PubMed ID: 1096179
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents].
    García Heredia M; García SD; Copolillo EF; Cora Eliseth M; Barata AD; Vay CA; de Torres RA; Tiraboschi N; Famiglietti AM
    Rev Argent Microbiol; 2006; 38(1):9-12. PubMed ID: 16784126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antifungal agents. 10. Synthesis and antifungal activities of aryl-(1H-imidazol-1-yl)-(isoquinolin-1-yl) methane derivatives.
    Silvestri R; Pagnozzi E; Troccoli F; Stefancich G; Massa S; Apuzzo G; Perazzi ME; Artico M; Simonetti G
    Farmaco; 1995 Apr; 50(4):227-38. PubMed ID: 7669167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential fungicidal effect of voriconazole against Candida spp.
    Rubio MC; de Ocáriz IR; Gil J; Benito R; Rezusta A
    Int J Antimicrob Agents; 2005 Mar; 25(3):264-7. PubMed ID: 15737524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antifungal effect of high- and low-molecular-weight chitosan hydrochloride, carboxymethyl chitosan, chitosan oligosaccharide and N-acetyl-D-glucosamine against Candida albicans, Candida krusei and Candida glabrata.
    Seyfarth F; Schliemann S; Elsner P; Hipler UC
    Int J Pharm; 2008 Apr; 353(1-2):139-48. PubMed ID: 18164151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.